23.20
+0.80
+(3.57%)
At close: January 31 at 9:34:14 PM GMT+1
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 895.43k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| THRONE JASON Officer | Conversion of Exercise of derivative security at price 7.01 - 13.34 per share. | Direct | 415,587 | Jun 27, 2024 |
| WHITE MICHAEL ANTHONY Officer | Conversion of Exercise of derivative security at price 12.86 per share. | Direct | 366,510 | May 29, 2024 |
| WHITE MICHAEL ANTHONY Officer | Sale at price 36.23 - 36.78 per share. | Direct | 1,032,884 | May 29, 2024 |
| HATA YUJIRO S. Chief Executive Officer | Conversion of Exercise of derivative security at price 4.31 per share. | Direct | 754,250 | May 16, 2024 |
| HATA YUJIRO S. Chief Executive Officer | Sale at price 41.60 - 44.12 per share. | Direct | 7,397,291 | May 16, 2024 |
| HATA YUJIRO S. Chief Executive Officer | Conversion of Exercise of derivative security at price 4.31 per share. | Direct | 428,293 | Feb 9, 2024 |
| HATA YUJIRO S. Chief Executive Officer | Sale at price 45.15 - 45.54 per share. | Direct | 4,495,550 | Feb 9, 2024 |
| RUIZ BRISENO ANDRES Officer | Sale at price 46.02 per share. | Direct | 92,045 | Feb 9, 2024 |
| HATA YUJIRO S. Chief Executive Officer | Conversion of Exercise of derivative security at price 4.31 per share. | Direct | 2,707 | Feb 1, 2024 |
| HATA YUJIRO S. Chief Executive Officer | Sale at price 45.00 - 45.01 per share. | Direct | 28,260 | Feb 1, 2024 |
| RUIZ BRISENO ANDRES Officer | Sale at price 42.03 per share. | Direct | 84,050 | Jan 22, 2024 |
| HATA YUJIRO S. Chief Executive Officer | Conversion of Exercise of derivative security at price 4.31 per share. | Direct | 323,250 | Jan 16, 2024 |
| HATA YUJIRO S. Chief Executive Officer | Sale at price 40.04 - 40.17 per share. | Direct | 3,010,882 | Jan 16, 2024 |
| RUIZ BRISENO ANDRES Officer | Sale at price 38.01 per share. | Direct | 76,026 | Jan 12, 2024 |
| THRONE JASON Officer | Conversion of Exercise of derivative security at price 7.01 - 13.34 per share. | Direct | 203,500 | Dec 18, 2023 |
| HATA YUJIRO S. Chief Executive Officer | Conversion of Exercise of derivative security at price 4.31 per share. | Direct | 323,250 | Dec 15, 2023 |
| HATA YUJIRO S. Chief Executive Officer | Sale at price 35.03 per share. | Direct | 2,627,618 | Dec 15, 2023 |
| THRONE JASON Officer | Sale at price 35.04 per share. | Direct | 350,371 | Dec 15, 2023 |
| RUIZ BRISENO ANDRES Officer | Sale at price 34.00 per share. | Direct | 68,002 | Dec 14, 2023 |
| THRONE JASON Officer | Conversion of Exercise of derivative security at price 12.86 per share. | Direct | 66,396 | Nov 3, 2023 |
| THRONE JASON Officer | Sale at price 30.09 per share. | Direct | 155,360 | Nov 3, 2023 |
| THRONE JASON Officer | Conversion of Exercise of derivative security at price 12.86 per share. | Direct | 12,860 | Sep 12, 2023 |
| THRONE JASON Officer | Sale at price 30.00 - 30.01 per share. | Direct | 30,005 | Sep 12, 2023 |
| THRONE JASON Officer | Conversion of Exercise of derivative security at price 12.86 per share. | Direct | 49,344 | Sep 5, 2023 |
| THRONE JASON Officer | Sale at price 30.03 per share. | Direct | 115,222 | Sep 5, 2023 |
| RUIZ BRISENO ANDRES Officer | Sale at price 30.01 per share. | Direct | 60,016 | Sep 1, 2023 |
| STONE PAUL A Chief Financial Officer | Sale at price 28.87 per share. | Direct | 144,352 | Aug 29, 2023 |
| STONE PAUL A Chief Financial Officer | Sale at price 26.40 per share. | Direct | 25,819 | Aug 21, 2023 |
| STONE PAUL A Chief Financial Officer | Sale at price 26.38 - 26.45 per share. | Direct | 106,105 | Aug 18, 2023 |
| THRONE JASON Officer | Conversion of Exercise of derivative security at price 13.34 per share. | Direct | 66,700 | Aug 9, 2023 |
| STONE PAUL A Chief Financial Officer | Sale at price 25.05 per share. | Direct | 62,613 | Aug 9, 2023 |
| THRONE JASON Officer | Sale at price 25.09 per share. | Direct | 125,430 | Aug 9, 2023 |
| THRONE JASON Officer | Conversion of Exercise of derivative security at price 7.01 - 12.86 per share. | Direct | 95,740 | Jul 10, 2023 |
| THRONE JASON Officer | Sale at price 23.00 per share. | Direct | 218,178 | Jul 10, 2023 |
| THRONE JASON Officer | Conversion of Exercise of derivative security at price 7.01 per share. | Direct | 27,935 | Jun 1, 2023 |
| THRONE JASON Officer | Sale at price 23.00 - 23.02 per share. | Direct | 91,729 | Jun 1, 2023 |
| THRONE JASON Officer | Conversion of Exercise of derivative security at price 7.01 per share. | Direct | 3,505 | May 22, 2023 |
| THRONE JASON Officer | Sale at price 23.00 per share. | Direct | 11,500 | May 22, 2023 |
| STONE PAUL A Chief Financial Officer | Conversion of Exercise of derivative security at price 4.62 per share. | Direct | 36,960 | Apr 13, 2023 |
| HATA YUJIRO S. Chief Executive Officer | Conversion of Exercise of derivative security at price 4.31 per share. | Direct | 50,000 | Apr 12, 2023 |
Related Tickers
SER Serina Therapeutics, Inc.
4.7000
+2.17%
AADI Aadi Bioscience, Inc.
2.8800
0.00%
CELC Celcuity Inc.
11.95
+1.96%
THTX Theratechnologies Inc.
1.4400
+0.70%
APGE Apogee Therapeutics, Inc.
41.36
-2.68%
VRDN Viridian Therapeutics, Inc.
19.38
-3.49%
ADCT ADC Therapeutics SA
1.6800
-2.33%
CRNX Crinetics Pharmaceuticals, Inc.
40.30
+0.10%
OVID Ovid Therapeutics Inc.
0.6634
-5.24%
COGT Cogent Biosciences, Inc.
9.31
-3.22%